CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest-Reference-Cited by-同舟云学术

CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest

Published:2018-11 Issue:11 Volume:28 Page:911-925
ISSN:0962-8924
Container-title:Trends in Cell Biology
language:en
Short-container-title:Trends in Cell Biology

Author:

Goel Shom,DeCristo Molly J.,McAllister Sandra S.,Zhao Jean J.

Publisher

Elsevier BV

Subject

Cell Biology

Reference123 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts;Fry;Mol. Cancer Ther.,2004

3. LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6-reactivating Rb in cancer;Kim;Mol. Cancer Ther.,2014

4. Preclinical characterization of the CDK4/6 inhibitor LY2835219: in vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine;Gelbert;Invest. New Drugs,2014

5. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro;Finn;Breast Cancer Res.,2009

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo;Frontiers of Medicine;2024-09-13

2. Abemaciclib Therapy Using the MonarchE Criteria Results in Large Numbers of Excess Axillary Node Clearances—Time to Pause and Reflect?;Cancers;2024-09-04

3. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09

4. CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer;Advanced Science;2024-08-13

5. Impact of protein and small molecule interactions on kinase conformations;ELIFE;2024